Women's Health News

RSS

Sugary drinks do not promote weight gain in overweight women: Research

New research from Queen Margaret University, Edinburgh, shows that sugary drinks, consumed in moderate quantities, do not promote weight gain, carbohydrate craving or adverse mood effects in overweight women when they do not know what they are drinking.

11 Aug 2010

Agile initiates Phase 3 NEW CHOICE Study of AG200-15 contraceptive patch

Agile Therapeutics, Inc., a pharmaceutical development company specializing in women's healthcare products, today announced study initiation and dosing of the first patient in the Company's pivotal, Phase 3 NEW CHOICE Study of AG200-15, Agile's lead contraceptive patch. AG200-15 is designed to effectively deliver a low dose of estrogen in combination with levonorgestrel. The patch is applied once weekly for three weeks followed by a patch-free week.

11 Aug 2010

WCRF statistics: Breast cancer rates are higher in the UK

Breast cancer rates are more than four times higher in the UK than they are in eastern Africa, figures show. Statistics published by the World Cancer Research Fund show that 87.9 per 100,000 women in the UK were diagnosed with breast cancer in 2008, compared to just 19.3 per 100,000 in eastern Africa.

11 Aug 2010

Depomed announces SPA agreement with FDA for Serada Phase 3 trial for menopausal hot flashes

Depomed, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration regarding a Special Protocol Assessment on the design and analysis of Breeze 3, a Phase 3 trial evaluating Serada® (extended release gabapentin tablets) for menopausal hot flashes.

11 Aug 2010

Study finds hormone replacement therapy increases breast cancer risk

A new analysis of the California Teachers Study, which analyzed hormone replacement therapy use among 2,857 women for almost 10 years, underscores the need for personalized risk-benefit discussions before women begin hormone therapy."This is evidence that the story is complicated," said Tanmai Saxena, an M.D./Ph.D. student at the Keck School of Medicine at the University of Southern California. "The benefits of hormone therapy for relief of postmenopausal symptoms among women are clear, but the risks are more complicated than we had previously thought."

11 Aug 2010

Brain morphological changes associated with cyclic menstrual pain

Primary dysmenorrhea, or menstrual cramps, is the most common gynecological disorder in women of childbearing age. Lower abdominal pain starts with the onset of menstrual flow and this ongoing pain stimulus can cause alterations throughout the nervous system. In a study scheduled for publication in the September issue of PAIN, researchers report abnormal changes in the structure of the brain in PDM patients, whether or not they are in fact experiencing pain.

11 Aug 2010

Clarient receives patent for Mammostrat breast cancer prognostic test

Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.

11 Aug 2010

Progestins have tumor-stage specific effects that determine promotion, suppression: Study

Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used.

11 Aug 2010

Lancet World Report examines how U.N. Women agency will work to address global health issues

A Lancet World Report article examines how many are looking to the new U.N. agency tasked with advancing women's equality and rights to help improve the health of women in developing countries.

10 Aug 2010

Research on role of ADAM12 gene in breast cancer

A microscopic gene may play a gigantic role when it comes to cancerous tissue in the human body, according to one Kansas State University research team.The team is investigating mutation within the ADAM12 gene of the A Disintegrin and Metalloprotease family, or ADAM family, and its role in breast cancer."We want to know whether ADAM12 is a good guy or a bad guy in breast cancer," said Anna Zolkiewska, associate professor of biochemistry and research team leader.

10 Aug 2010

Scientist to research on molecular machinery of breast cancer

Someone in the world is diagnosed with breast cancer every 23 seconds. It is the leading cause of cancer death worldwide among women and approximately 456,000 die from the disease each year. At The University of Texas Health Science Center at Houston (UTHealth), a scientist is taking aim at the molecular machinery behind this disease.

10 Aug 2010

Study to evaluate sensitivity of mammography combined with somo•v ABUS technology in breast cancer screening

Henry Ford West Bloomfield Hospital announced today that it has joined U-Systems national clinical research study designed to evaluate whether digital mammography, when combined with the somo•v Automated Breast Ultrasound System (ABUS) from U-Systems, Inc (Sunnyvale, CA), is more sensitive in detecting breast lesions compared to mammography alone in women with dense breasts. Henry Ford West Bloomfield Hospital is the only site in Michigan, and one of only ten breast cancer centers in the entire country, currently recruiting women for the SOMO•INSIGHT clinical study.

10 Aug 2010

Curis announces preliminary results of GDC-0449 Phase II clinical trial in advanced ovarian cancer

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has received preliminary results from a Phase II clinical trial of GDC-0449 from Roche and Genentech, Curis' collaborator and a member of the Roche Group.

9 Aug 2010

Fiber hair cosmetics safe and effective for women with moderate hair loss: Study

Hair is considered a woman's "crowning glory," but women with thinning hair and those with curly, textured hair may face considerable challenges in keeping their hair looking its best. Fortunately, there are many different hair care products, or hair cosmetics, that can help conceal thinning hair and also keep textured hair in check.

7 Aug 2010

Oil Can Henry's customers raise $45,401 to support Susan G. Komen for the Cure

Oil Can Henry's customers rose to the challenge in July and helped the company raise $45,401 to support the Oregon and SW Washington Affiliate of Susan G. Komen for the Cure to help save lives and end breast cancer. Over the week-long fundraising effort, Oil Can Henry's locations in Oregon and Southwest Washington performed oil changes on 15,746 vehicles. In addition, customers had the opportunity to donate directly to Komen at the time of service.

7 Aug 2010

Female Health Company third-quarter net revenues decrease 75% to $1.8 million

The Female Health Company, which manufactures and markets the FC2 Female Condom®, today reported its operating results for the third quarter and first nine months of FY2010.

7 Aug 2010

Patient navigator program to educate Hmong women on cervical cancer

The Asian-American community of Hmong women in California carries a stunning burden of cervical cancer and resulting mortality four times as high as non-Hispanic white women in California do.

7 Aug 2010

Attractiveness detrimental for women applying for masculine sex-typed jobs

While many see no downside to being beautiful, a professor at the University of Colorado Denver Business School says attractive women face discrimination when it comes to landing certain kinds of jobs.

7 Aug 2010

Text4baby messaging program wins HHSinnovates award

Text4baby, a program of the National Healthy Mothers, Healthy Babies Coalition, has been honored with a U.S. Department of Health and Human Services HHSinnovates award, presented by HHS Secretary Kathleen Sebelius at a ceremony in Washington, DC. This week, Representatives from HMHB, Voxiva, Health Resources and Services Administration, Centers for Disease Control and Prevention and the HHS Office on Women's Health accepted the award on behalf of the text4baby team.

7 Aug 2010

Health reform provisions on abortion, IRS reporting requirements stirring up Capitol Hill

The Hill reports that Sens. Tom Coburn, R-Okla., and Orrin Hatch, R-Utah, introduced legislation Thursday "designed to eliminate a controversial provision of the Democrats' new healthcare reform law that allows subsidized plans to offer abortion coverage if patients pay separately, and with their own money, for that portion of the coverage.

7 Aug 2010